Skip to main content

Thermo, Fisher Shareholders Approve Merger; Regulatory OK Still Sought

NEW YORK (GenomeWeb News) – Thermo Electron and Fisher Scientific International today said that their shareholders have approved their merger.
 
The companies said that the deal, the largest ever in the biotech industry, remains subject to regulatory approval.
 
As GenomeWeb News reported this week, Fisher said it would divest an undisclosed product line to satisfy the Federal Trade Commission.  The line is worth $17 million, Fisher said.
 
As originally expected, the $10.6 billion deal is scheduled to close by the end of the fourth quarter. The firms announced the deal in May.
The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.